Stay updated on Pembrolizumab Combo in mCRPC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo in mCRPC Clinical Trial page.

Latest updates to the Pembrolizumab Combo in mCRPC Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe Locations section was updated with a large number of new trial sites across multiple countries (US, Canada, Europe, Asia, Australia, and South America), expanding where patients may enroll. At the same time, many existing locations were removed, indicating a restructuring of site availability.SummaryDifference4%

- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedRevision updated from v3.3.1 to v3.3.2. This appears to be a minor backend/UI update and does not change the study content or results.SummaryDifference0.0%

- Check37 days agoChange DetectedPublications are provided voluntarily by the person entering information and are automatically filled in from PubMed, a public database of scientific and medical articles, and may or may not be about the study. Revision updated from v3.2.0 to v3.3.1, and to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check45 days agoChange DetectedRemoved the banner about a lapse in government funding and directions to cc.nih.gov and opm.gov for updates.SummaryDifference0.1%

- Check59 days agoChange DetectedAdded Cali, Valle del Cauca Department, Colombia, 760042 to Locations and removed Santiago de Cali, Valle del Cauca Department, Colombia, 760042 from Locations.SummaryDifference0.2%

- Check88 days agoChange DetectedPage updated to Revision: v3.2.0 from Revision: v3.0.2; indicates a new release version with no other substantive content changes.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab Combo in mCRPC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in mCRPC Clinical Trial page.